These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2218804)

  • 1. Medical surveillance for melanoma at the Lawrence Livermore National Laboratory.
    Wald PH; Schneider JS
    Occup Med; 1990; 5(3):607-16. PubMed ID: 2218804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.
    Schneider JS; Moore DH; Mendelsohn ML
    J Am Acad Dermatol; 2008 May; 58(5):741-9. PubMed ID: 18068264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early diagnosis of cutaneous malignant melanoma at Lawrence Livermore National Laboratory.
    Schneider JS; Moore DH; Sagebiel RW
    Arch Dermatol; 1990 Jun; 126(6):767-9. PubMed ID: 2346320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer incidence rates among Lawrence Livermore National Laboratory (LLNL) employees: 1974-1997.
    Whorton MD; Moore DN; Seward JP; Noonan KA; Mendelsohn ML
    Am J Ind Med; 2004 Jan; 45(1):24-33. PubMed ID: 14691966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer incidence among employees of the Lawrence Livermore National Laboratory, 1969-1980.
    Reynolds P; Austin DF
    West J Med; 1985 Feb; 142(2):214-8. PubMed ID: 4013251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of malignant melanoma among employees of the Lawrence Livermore National Laboratory.
    Moore DH; Patterson HW; Hatch F; Discher D; Schneider JS; Bennett D; Mendelsohn ML
    Am J Ind Med; 1997 Oct; 32(4):377-91. PubMed ID: 9258392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible effect of increased surveillance on the incidence of malignant melanoma.
    Hiatt RA; Fireman B
    Prev Med; 1986 Nov; 15(6):652-60. PubMed ID: 3797396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant melanoma among employees of Lawrence Livermore National Laboratory.
    Austin DF; Reynolds PJ; Snyder MA; Biggs MW; Stubbs HA
    Lancet; 1981 Oct; 2(8249):712-6. PubMed ID: 6116857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance bias and the excess risk of malignant melanoma among employees of the Lawrence Livermore National Laboratory.
    Hiatt RA; Krieger N; Sagebiel RW; Clark WH; Mihm MC
    Epidemiology; 1993 Jan; 4(1):43-7. PubMed ID: 8420580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of melanoma: an educational campaign in Padova, Italy.
    Rossi CR; Vecchiato A; Bezze G; Mastrangelo G; Montesco MC; Mocellin S; Meneghetti G; Mazzoleni F; Peserico A; Nitti D; Lise M
    Melanoma Res; 2000 Apr; 10(2):181-7. PubMed ID: 10803719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of an excess of melanoma among employees of the Lawrence Livermore National Laboratory.
    Austin DF; Reynolds P
    Am J Epidemiol; 1997 Mar; 145(6):524-31. PubMed ID: 9063342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant melanoma incidence at the Los Alamos National Laboratory.
    Acquavella JF; Tietjen GL; Wilkinson GS; Key CR; Voelz GL
    Lancet; 1982 Apr; 1(8277):883-4. PubMed ID: 6122103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: a report of 47 cases.
    Manganoni AM; Farisoglio C; Tucci G; Facchetti F; Calzavara Pinton PG
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1333-6. PubMed ID: 17958838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the National Ignition Facility distinguishable-from-background program to accelerator facilities at Lawrence Livermore National Laboratory.
    Packard ED; Mac Kenzie C
    Health Phys; 2013 Jun; 104(6):633-40. PubMed ID: 23629069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protecting yourself against melanoma.
    Johns Hopkins Med Lett Health After 50; 2009 Jul; 21(5):6-7. PubMed ID: 19623739
    [No Abstract]   [Full Text] [Related]  

  • 16. Melanoma early detection.
    Terushkin V; Halpern AC
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):481-500, viii. PubMed ID: 19464598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of self-reported skin screening histories.
    Aitken JF; Youl PH; Janda M; Elwood M; Ring IT; Lowe JB; Firman DW
    Am J Epidemiol; 2004 Jun; 159(11):1098-105. PubMed ID: 15155295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma in situ in Puerto Rico: clinical characteristics and detection patterns.
    Muñoz C; Vázquez-Botet M
    P R Health Sci J; 2004 Sep; 23(3):179-82. PubMed ID: 15631171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploratory analysis of the occupational correlates of large pigmented nevi at Lawrence Livermore National Laboratory.
    Schwartzbaum JA; Setzer RW; Kupper LL
    J Occup Med; 1990 Jul; 32(7):605-11. PubMed ID: 2391573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous melanoma at Lawrence Livermore National Laboratory: comparison with rates in two San Francisco bay area counties.
    Gong G; Whittemore AS; West D; Moore DH
    Cancer Causes Control; 1992 May; 3(3):191-7. PubMed ID: 1610965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.